Literature DB >> 10860196

The cost-effectiveness of exercise training for the primary and secondary prevention of cardiovascular disease.

I Lowensteyn1, L Coupal, H Zowall, S A Grover.   

Abstract

BACKGROUND: Although exercise training improves cardiovascular disease (CVD) risk factors, few studies have evaluated its potential long-term cost-effectiveness.
METHODS: Using the Cardiovascular Disease Life Expectancy Model, a validated disease simulation model, we calculated the life expectancy of average 35- to 74-year-old Canadians found in the 1992 Canadian Heart Health Survey. The impacts of exercise training on cardiovascular risk factors were estimated as a 4% decrease in low-density lipoprotein (LDL) cholesterol, a 5% increase in high-density lipoprotein (HDL) cholesterol, and a 6 mm Hg decrease in both systolic and diastolic blood pressure. Exercise adherence was estimated at 50% for the first year and 30% for all additional years. Costs for a supervised exercise program determined from Canadian sources and converted to US dollars were estimated at $605 for the first year (medical evaluation, stress test, exercise prescription, and program costs) and $367 for all additional years (program costs). For an unsupervised program, the costs were estimated at $311 for the first year and $73 for all additional years.
RESULTS: The cost-effectiveness (CE) of an unsupervised exercise program (1996 U.S. dollars) was less than $12,000 per year of life saved (YOLS) for all individuals. The CE of a supervised exercise program was less than $15,000/YOLS for men with CVD, and between $12,000 and $43,000 for women with CVD and men without CVD.
CONCLUSIONS: Given the relatively few risks, substantial long-term benefits, and modest costs, an unsupervised exercise training program represents good value for all. A more expensive supervised exercise program is also cost-effective for most individuals with CVD.

Entities:  

Mesh:

Year:  2000        PMID: 10860196     DOI: 10.1097/00008483-200005000-00002

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil        ISSN: 0883-9212            Impact factor:   2.081


  12 in total

Review 1.  A review of health care models for coronary heart disease interventions.

Authors:  K Cooper; S C Brailsford; R Davies; J Raftery
Journal:  Health Care Manag Sci       Date:  2006-11

Review 2.  Improving risk factor modification: a global approach.

Authors:  Tshaka Muchiteni; William B Borden
Journal:  Curr Cardiol Rep       Date:  2009-11       Impact factor: 2.931

3.  Feasibility, Acceptability and Effects of a Home-Based Exercise Program Using a Gerontechnology on Physical Capacities after a Minor Injury in Community-Living Older Adults: A Pilot Study.

Authors:  M Lauzé; D D Martel; A Agnoux; M-J Sirois; M Émond; R Daoust; M Aubertin-Leheudre
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

4.  Endovascular management of aortoiliac occlusive disease.

Authors:  Melissa J Neisen
Journal:  Semin Intervent Radiol       Date:  2009-12       Impact factor: 1.513

Review 5.  Narrative review comparing the benefits of and participation in cardiac rehabilitation in high-, middle- and low-income countries.

Authors:  Karam I Turk-Adawi; Sherry L Grace
Journal:  Heart Lung Circ       Date:  2014-11-29       Impact factor: 2.975

6.  Preventive care utilization: Association with individual- and workgroup-level policy and practice perceptions.

Authors:  Erika L Sabbath; Emily H Sparer; Leslie I Boden; Gregory R Wagner; Dean M Hashimoto; Karen Hopcia; Glorian Sorensen
Journal:  Prev Med       Date:  2018-03-19       Impact factor: 4.018

7.  Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial.

Authors:  Tanja Krones; Heidemarie Keller; Andreas Sönnichsen; Eva-Maria Sadowski; Erika Baum; Karl Wegscheider; Justine Rochon; Norbert Donner-Banzhoff
Journal:  Ann Fam Med       Date:  2008 May-Jun       Impact factor: 5.166

Review 8.  A systematic review of economic evaluations of cardiac rehabilitation.

Authors:  Wai Pong Wong; Jun Feng; Keng Ho Pwee; Jeremy Lim
Journal:  BMC Health Serv Res       Date:  2012-08-08       Impact factor: 2.655

9.  Psychosocial stress and cardiovascular disease. Part 3: Clinical and policy implications of research on the transcendental meditation program.

Authors:  Kenneth G Walton; Robert H Schneider; John W Salerno; Sanford I Nidich
Journal:  Behav Med       Date:  2005       Impact factor: 3.879

10.  A Cost-Effective Analysis of the CYCLE-HD Randomized Controlled Trial.

Authors:  Daniel S March; Adam W Hurt; Charlotte E Grantham; Darren R Churchward; Hannah M L Young; Patrick J Highton; Maurice Dungey; Nicolette C Bishop; Alice C Smith; Matthew P M Graham-Brown; Nicola J Cooper; James O Burton
Journal:  Kidney Int Rep       Date:  2021-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.